MTEX

Mannatech, Incorporated [MTEX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MTEX Stock Summary

Top 10 Correlated Stocks

MTEX


In the News

09:00 30 Nov 2023 MTEX

Mannatech - Expected May/June Tender Offer - Price Jump

Mannatech, a multi-level-marketing company, tends to announce a large tender offer before its annual June shareholders' meeting; A new large tender offer may be launched shortly;

11:49 30 Nov 2023 MTEX

Mannatech: Small But Mighty Health Food Pick

Mannatech is a little-known wellness, nutrition and dietary supplement outfit with an extremely low valuation vs. peers. Pandemic forces in the economy have resulted in strong free cash flow generation, with much better final margins on sales.

10:01 30 Nov 2023 MTEX

7 Top-Rated Pharmaceutical Stocks To Invest in for October

It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures. The post 7 Top-Rated Pharmaceutical Stocks To Invest in for October appeared first on InvestorPlace.

02:23 30 Nov 2023 MTEX

Mannatech Plans $1M Buyback Program

Mannatech Inc (NASDAQ: MTEX) Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The buyback program will begin on September 21, 2021, and ends on the earlier of September 21, 2022, or purchase of $1 mln common stock.

06:00 30 Nov 2023 MTEX

Mannatech Announces Share Repurchase Program

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech”), today announced that its Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The authorized repurchases will be made from time to time in the open market, through block trades or in privately negotiated transactions. The timing, volume and nature of share repurchases will be at the discretion of management and dependent on market cond

05:15 30 Nov 2023 MTEX

Mannatech Declares Second Quarter 2021 Dividend

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 29, 2021, to shareholders of record at the close of business on Wednesday, September 15, 2021. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment

06:00 30 Nov 2023 MTEX

Mannatech Reports Second Quarter End 2021 Financial Results

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech Reports Second Quarter End 2021 Financial Results

06:00 30 Nov 2023 MTEX

Mannatech Announces Final Results of Tender Offer

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the final results of its cash tender offer, which expired at 12:00 midnight, New York City time, at the end of Friday, June 25, 2021, to purchase up to 211,538 shares of its outstanding common stock, par value $0.0001 per share, at a per share price of $26.00 (the "tender offer").

05:40 30 Nov 2023 MTEX

Mannatech Announces Preliminary Results of Tender Offer

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the preliminary results of its cash tender offer, which expired at 12:00 midnight, New York City time, at the end of Friday, June 25, 2021, to purchase up to 211,538 shares of its outstanding common stock, par value $0.0001 per share, at a per share price of $26.00 (the "tender of

05:00 30 Nov 2023 MTEX

Mannatech Announces Results of Annual Shareholders' Meeting

FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 15, 2021. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech's Chief Financial Officer, spoke to the shareholders sh

MTEX Financial details

Company Rating
Buy
Market Cap
16.85M
Income
-7.5M
Revenue
133.6M
Book val./share
5.74
Cash/share
4.26
Dividend
0.6
Dividend %
6.67%
Employees
228
Optionable
No
Shortable
Yes
Earnings
07 Nov 2023
P/E
-2.23
Forward P/E
-
PEG
0.12
P/S
0.13
P/B
1.57
P/C
2.14
P/FCF
-3.47
Quick Ratio
0.32
Current Ratio
1.09
Debt / Equity
0.15
LT Debt / Equity
0.1
-
-
EPS (TTM)
-4.04
EPS next Y
-
EPS next Q
2.09
EPS this Y
-147.47%
EPS next Y
-
EPS next 5Y
-416.83%
EPS last 5Y
8.96%
Revenue last 5Y
-4.59%
Revenue Q/Q
-0.13%
EPS Q/Q
-101.69%
-
-
-
-
SMA20
-
SMA50
-18.18%
SMA100
-25%
Inst Own
16.88%
Inst Trans
0.7%
ROA
-18%
ROE
-60%
ROC
-0.17%
Gross Margin
76%
Oper. Margin
-2%
Profit Margin
-6%
Payout
-15%
Shs Outstand
1.86M
Shs Float
900.59K
-
-
-
-
Target Price
-
52W Range
8.0-24.1
52W High
-62.09%
52W Low
+13.74%
RSI
49
Rel Volume
0.67
Avg Volume
1.56K
Volume
1.04K
Perf Week
-2.12%
Perf Month
-7.15%
Perf Quarter
-27.21%
Perf Half Y
-27.21%
-
-
-
-
Beta
1.199
-
-
Volatility
0.32%, 0.34%
Prev Close
1.21%
Price
9.099
Change
-2.16%

MTEX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
68.365.9767.7480.2871.72
Net income per share
-1.531.382.84.95-2.35
Operating cash flow per share
-0.092.062.75.41-1.36
Free cash flow per share
-1.011.552.275.09-1.91
Cash per share
8.610.369.9412.157.2
Book value per share
9.9711.4111.6212.277.41
Tangible book value per share
9.8911.4111.6212.277.41
Share holders equity per share
9.9711.4111.6212.277.41
Interest debt per share
0.790.560.380.170.26
Market cap
47.77M38.47M41.57M76.26M34.24M
Enterprise value
27.66M15.07M20.12M52.41M20.88M
P/E ratio
-12.2911.76.647.75-7.63
Price to sales ratio
0.280.240.270.480.25
POCF ratio
-215.187.826.897.08-13.18
PFCF ratio
-18.6610.418.187.53-9.35
P/B Ratio
1.891.411.63.122.42
PTB ratio
1.891.411.63.122.42
EV to sales
0.160.10.130.330.15
Enterprise value over EBITDA
14.011.773.14.8717.08
EV to operating cash flow
-124.583.073.344.86-8.03
EV to free cash flow
-10.84.083.965.18-5.7
Earnings yield
-0.080.090.150.13-0.13
Free cash flow yield
-0.050.10.120.13-0.11
Debt to equity
0.070.050.030.010.03
Debt to assets
0.030.020.010.010.01
Net debt to EBITDA
-10.19-2.75-3.31-2.21-10.94
Current ratio
1.261.421.331.421.17
Interest coverage
-0.31-402.0654.110-4.6
Income quality
0.061.490.961.090.58
Dividend Yield
0.060.030.080.060.04
Payout ratio
-0.790.360.540.44-0.34
Sales general and administrative to revenue
0.420.20.180.180.2
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
10.53-0.25-0.16-0.060.41
Capex to revenue
-0.01-0.01-0.010-0.01
Capex to depreciation
-1.13-0.58-0.48-0.38-0.65
Stock based compensation to revenue
0.010000
Graham number
18.5218.7927.0636.9519.78
ROIC
0.030.130.180.4-0.26
Return on tangible assets
-0.060.050.10.17-0.09
Graham Net
-3.27-2.06-4.41-2.36-6.97
Working capital
8.77M12.14M10.49M12.74M5.12M
Tangible asset value
25.12M27.28M25.97M24.41M14.18M
Net current asset value
5.51M5.38M3.11M7.63M1000
Invested capital
0.070.050.030.010.03
Average receivables
788.5K786K1.18M813K536.5K
Average payables
6.37M5.13M4.16M4.38M4.17M
Average inventory
11.1M11.49M11.49M12.42M13.37M
Days sales outstanding
0.832.722.880.991.71
Days payables outstanding
71.1940.7949.3142.4248.15
Days of inventory on hand
135.74117.45131.86128.48162.58
Receivables turnover
437.17134.24126.81369.82214.05
Payables turnover
5.138.957.48.67.58
Inventory turnover
2.693.112.772.842.25
ROE
-0.150.120.240.4-0.32
Capex per share
-0.92-0.51-0.42-0.33-0.56

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
18.6318.4718.2217.4317.47
Net income per share
0.62-3.780.32-0.590.01
Operating cash flow per share
-0.53-1.640.72-1.440.15
Free cash flow per share
-0.72-1.740.67-1.570.05
Cash per share
7.927.417.315.014.26
Book value per share
9.767.637.46.235.74
Tangible book value per share
9.767.637.46.125.74
Share holders equity per share
9.767.637.46.235.74
Interest debt per share
3.360.240.833.80.85
Market cap
39.64M33.28M32.29M22.46M19.28M
Enterprise value
30.94M19.91M20.52M20.18M12.95M
P/E ratio
8.32-1.1913.37-5.08267.81
Price to sales ratio
1.120.970.950.690.59
POCF ratio
-39.1-10.8823.9-8.3667.18
PFCF ratio
-29-10.325.9-7.65190.91
P/B Ratio
2.132.352.331.931.8
PTB ratio
2.132.352.331.931.8
EV to sales
0.870.580.60.620.4
Enterprise value over EBITDA
14.93-8.3918.65-48.420.82
EV to operating cash flow
-30.52-6.5115.19-7.5145.13
EV to free cash flow
-22.64-6.1616.45-6.87128.23
Earnings yield
0.03-0.210.02-0.050
Free cash flow yield
-0.03-0.10.04-0.130.01
Debt to equity
0.340.030.140.610.15
Debt to assets
0.120.010.040.160.04
Net debt to EBITDA
-4.25.63-10.75.45-10.18
Current ratio
1.271.171.171.111.09
Interest coverage
71.42-85.48-2-95.4-10.12
Income quality
-0.850.472.242.4315.94
Dividend Yield
0.010.010.010.020
Payout ratio
0.32-0.050.62-0.340
Sales general and administrative to revenue
0.190.20.190.220.21
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
0.350.06-0.080.09-0.65
Capex to revenue
-0.01-0.010-0.01-0.01
Capex to depreciation
-0.49-0.63-0.27-0.65-0.41
Stock based compensation to revenue
000.0100
Graham number
11.7225.457.339.11.12
ROIC
0.03-0.350.02-0.050
Return on tangible assets
0.02-0.140.01-0.020
Graham Net
-5.61-7.17-8.06-8.38-8.31
Working capital
7.71M5.12M5.2M3.01M2.27M
Tangible asset value
18.61M14.18M13.85M11.44M10.7M
Net current asset value
2.55M1000-413K-2.51M-2.92M
Invested capital
0.340.030.140.610.15
Average receivables
619K639.5K611.5K824.5K817K
Average payables
4.86M4.47M5.01M5.74M4.85M
Average inventory
14.57M14.99M15.02M15.58M15.59M
Days sales outstanding
1.621.681.542.951.57
Days payables outstanding
55.5936.9168.7574.8552.7
Days of inventory on hand
185.08124.64186203.52208.28
Receivables turnover
55.6653.5658.6230.5557.41
Payables turnover
1.622.441.311.21.71
Inventory turnover
0.490.720.480.440.43
ROE
0.06-0.50.04-0.090
Capex per share
-0.19-0.09-0.06-0.13-0.1

MTEX Frequently Asked Questions

What is Mannatech, Incorporated stock symbol ?

Mannatech, Incorporated is a US stock , located in Flower mound of Tx and trading under the symbol MTEX

What is Mannatech, Incorporated stock quote today ?

Mannatech, Incorporated stock price is $9.099 today.

Is Mannatech, Incorporated stock public?

Yes, Mannatech, Incorporated is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap